• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

低级别浆液性上皮性卵巢癌:放射科医生的全面综述与更新

Low-grade serous epithelial ovarian cancer: a comprehensive review and update for radiologists.

作者信息

Amante Sofia, Santos Filipa, Cunha Teresa Margarida

机构信息

Department of Radiology, Hospital do Divino Espírito Santo de Ponta Delgada, Avenida D. Manuel I, 9500-370, Ponta Delgada, Azores, Portugal.

Department of Pathology, Instituto Português de Oncologia de Lisboa Francisco Gentil, Lisbon, Portugal.

出版信息

Insights Imaging. 2021 May 11;12(1):60. doi: 10.1186/s13244-021-01004-7.

DOI:10.1186/s13244-021-01004-7
PMID:33974157
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8113429/
Abstract

Low-grade serous carcinoma (LGSC) is an infrequent subtype of ovarian cancer, corresponding to 5% of epithelial neoplasms. This subtype of ovarian carcinoma characteristically has molecular features, pathogenesis, clinical behaviour, sensitivity to chemotherapy, and prognosis distinct to high-grade serous carcinoma (HGSC). Knowing the difference between LGSC and other ovarian serous tumours is vital to guide clinical management, which currently is only possible histologically. However, imaging can provide several clues that allow differentiating LGSC from other tumours and enable precise staging and follow-up of ovarian cancer treatment. Characteristically, LGSC appears as mixed lesions with variable papillary projections and solid components, usually in different proportions from those detected in serous borderline tumour and HGSC. Calcified extracellular bodies, known as psammoma bodies, are also a common feature of LGSC, frequently detectable within lymphadenopathies and metastases associated with this type of tumour. In addition, the characterisation of magnetic resonance imaging enhancement also plays an essential role in calculating the probability of malignancy of these lesions. As such, in this review, we discuss and update the distinct radiological modalities features and the clinicopathologic characteristics of LGSC to allow radiologists to be familiarised with them and to narrow the differential diagnosis when facing this type of tumour.

摘要

低级别浆液性癌(LGSC)是一种罕见的卵巢癌亚型,占上皮性肿瘤的5%。这种卵巢癌亚型具有独特的分子特征、发病机制、临床行为、化疗敏感性和预后,与高级别浆液性癌(HGSC)不同。了解LGSC与其他卵巢浆液性肿瘤之间的差异对于指导临床管理至关重要,目前只有通过组织学检查才能做到。然而,影像学检查可以提供一些线索,有助于将LGSC与其他肿瘤区分开来,并实现卵巢癌治疗的精确分期和随访。典型的是,LGSC表现为具有不同乳头样突起和实性成分的混合性病变,其比例通常与浆液性交界性肿瘤和HGSC不同。钙化的细胞外小体,即砂粒体,也是LGSC的一个常见特征,在与这类肿瘤相关的淋巴结病和转移灶中经常可以检测到。此外,磁共振成像增强的特征在计算这些病变的恶性概率方面也起着重要作用。因此,在本综述中,我们讨论并更新了LGSC独特的影像学特征和临床病理特征,以使放射科医生熟悉这些特征,并在面对这类肿瘤时缩小鉴别诊断范围。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ef9/8113429/8b51656de540/13244_2021_1004_Fig11_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ef9/8113429/1e2d01c14fb8/13244_2021_1004_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ef9/8113429/f6d386e15928/13244_2021_1004_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ef9/8113429/75012f40bfba/13244_2021_1004_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ef9/8113429/c2f1c5cf7d36/13244_2021_1004_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ef9/8113429/6b2c87f6bdcd/13244_2021_1004_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ef9/8113429/236e6dc13611/13244_2021_1004_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ef9/8113429/cdedb4ce6640/13244_2021_1004_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ef9/8113429/5e65656be171/13244_2021_1004_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ef9/8113429/7179a3230019/13244_2021_1004_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ef9/8113429/2da02a48943f/13244_2021_1004_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ef9/8113429/8b51656de540/13244_2021_1004_Fig11_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ef9/8113429/1e2d01c14fb8/13244_2021_1004_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ef9/8113429/f6d386e15928/13244_2021_1004_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ef9/8113429/75012f40bfba/13244_2021_1004_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ef9/8113429/c2f1c5cf7d36/13244_2021_1004_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ef9/8113429/6b2c87f6bdcd/13244_2021_1004_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ef9/8113429/236e6dc13611/13244_2021_1004_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ef9/8113429/cdedb4ce6640/13244_2021_1004_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ef9/8113429/5e65656be171/13244_2021_1004_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ef9/8113429/7179a3230019/13244_2021_1004_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ef9/8113429/2da02a48943f/13244_2021_1004_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ef9/8113429/8b51656de540/13244_2021_1004_Fig11_HTML.jpg

相似文献

1
Low-grade serous epithelial ovarian cancer: a comprehensive review and update for radiologists.低级别浆液性上皮性卵巢癌:放射科医生的全面综述与更新
Insights Imaging. 2021 May 11;12(1):60. doi: 10.1186/s13244-021-01004-7.
2
Characterization of Primary Mucinous Ovarian Cancer by Diffusion-Weighted and Dynamic Contrast Enhancement MRI in Comparison with Serous Ovarian Cancer.通过扩散加权和动态对比增强MRI对原发性黏液性卵巢癌进行特征分析并与浆液性卵巢癌比较
Cancers (Basel). 2023 Feb 24;15(5):1453. doi: 10.3390/cancers15051453.
3
Changes in the tumour microenvironment mark the transition from serous borderline tumour to low-grade serous carcinoma.肿瘤微环境的改变标志着从浆液性交界性肿瘤向低级别浆液性癌的转变。
J Pathol. 2024 Oct;264(2):197-211. doi: 10.1002/path.6338. Epub 2024 Jul 31.
4
Ovarian Low-grade Serous Carcinoma: A Clinicopathologic Study of 33 Cases With Primary Surgery Performed at a Single Institution.卵巢低级别浆液性癌:对在单一机构进行初次手术的33例病例的临床病理研究
Am J Surg Pathol. 2016 May;40(5):627-35. doi: 10.1097/PAS.0000000000000615.
5
Combination of TP53 and AGR3 to distinguish ovarian high-grade serous carcinoma from low-grade serous carcinoma.联合检测 TP53 和 AGR3 有助于鉴别卵巢高级别浆液性癌与低级别浆液性癌。
Int J Oncol. 2018 Jun;52(6):2041-2050. doi: 10.3892/ijo.2018.4360. Epub 2018 Apr 4.
6
Ovarian serous tumors of low malignant potential with nodal low-grade serous carcinoma.低恶性潜能的卵巢浆液性肿瘤伴淋巴结低级别浆液性癌。
Am J Surg Pathol. 2012 Jul;36(7):955-63. doi: 10.1097/PAS.0b013e31825793e1.
7
Molecular Analysis of High-Grade Serous Ovarian Carcinoma Exhibiting Low-Grade Serous Carcinoma and Serous Borderline Tumor.表现为低级别浆液性癌和浆液性交界性肿瘤的高级别浆液性卵巢癌的分子分析
Curr Issues Mol Biol. 2024 Aug 25;46(9):9376-9385. doi: 10.3390/cimb46090555.
8
Imaging in gynecological disease (12): clinical and ultrasound features of invasive and non-invasive malignant serous ovarian tumors.妇科疾病影像学(十二):侵袭性和非侵袭性恶性浆液性卵巢肿瘤的临床和超声特征。
Ultrasound Obstet Gynecol. 2017 Dec;50(6):788-799. doi: 10.1002/uog.17414. Epub 2017 Nov 2.
9
Low-grade Serous Carcinoma of the Ovary: Clinicopathologic Analysis of 52 Invasive Cases and Identification of a Possible Noninvasive Intermediate Lesion.卵巢低级别浆液性癌:52例浸润性病例的临床病理分析及一种可能的非浸润性中间病变的鉴定
Am J Surg Pathol. 2016 Sep;40(9):1165-76. doi: 10.1097/PAS.0000000000000693.
10
Expression of serum human epididymal secretory protein E4 at low grade and high grade serous carcinomas.血清人附睾分泌蛋白 E4 在低级别和高级别浆液性癌中的表达。
Asian Pac J Trop Med. 2012 Dec;5(12):925-30. doi: 10.1016/S1995-7645(12)60175-8.

引用本文的文献

1
Radiologic and surgical peritoneal cancer index in patients with low grade serous ovarian carcinoma.低级别浆液性卵巢癌患者的放射学和手术腹膜癌指数
Gynecol Oncol Rep. 2025 Jul 16;60:101805. doi: 10.1016/j.gore.2025.101805. eCollection 2025 Aug.
2
Biomarkers in Ovarian Cancer: Towards Personalized Medicine.卵巢癌中的生物标志物:迈向个性化医疗。
Proteomes. 2024 Mar 18;12(1):8. doi: 10.3390/proteomes12010008.
3
Clinical Observations and Outcomes in Advanced Low-Grade Serous Carcinoma of the Ovary: Case Series from a Tertiary Cancer Center.

本文引用的文献

1
Benign Uterine Disease: The Added Role of Imaging.良性子宫疾病:影像学的附加作用。
Obstet Gynecol Clin North Am. 2021 Mar;48(1):193-214. doi: 10.1016/j.ogc.2020.12.002.
2
Borderline epithelial ovarian tumors: what the radiologist should know.卵巢交界性上皮性肿瘤:放射科医生应了解的内容。
Abdom Radiol (NY). 2021 Jun;46(6):2350-2366. doi: 10.1007/s00261-020-02688-z. Epub 2020 Aug 29.
3
Early detection of ovarian cancer.卵巢癌的早期检测。
晚期低级别浆液性卵巢癌的临床观察与转归:来自三级癌症中心的病例系列研究
Indian J Surg Oncol. 2023 Dec;14(4):784-792. doi: 10.1007/s13193-023-01775-z. Epub 2023 Jun 5.
4
Meta-analysis of microarray data to determine gene indicators involved in the cisplatin resistance in ovarian cancer.基于微阵列数据分析确定顺铂耐药卵巢癌相关基因标志物的研究
Cancer Rep (Hoboken). 2023 Dec;6(12):e1884. doi: 10.1002/cnr2.1884. Epub 2023 Nov 7.
5
The Discrepancy between Preoperative Tumor Markers and Imaging Outcomes in Predicting Ovarian Malignancy.术前肿瘤标志物与影像学结果在预测卵巢恶性肿瘤方面的差异
Cancers (Basel). 2022 Nov 25;14(23):5821. doi: 10.3390/cancers14235821.
6
The Role of Omics Approaches to Characterize Molecular Mechanisms of Rare Ovarian Cancers: Recent Advances and Future Perspectives.组学方法在表征罕见卵巢癌分子机制中的作用:最新进展与未来展望
Biomedicines. 2021 Oct 15;9(10):1481. doi: 10.3390/biomedicines9101481.
7
Transcriptome-based stemness indices analysis reveals platinum-based chemo-theraputic response indicators in advanced-stage serous ovarian cancer.基于转录组的干性指数分析揭示了晚期浆液性卵巢癌中基于铂类的化疗反应指标。
Bioengineered. 2021 Dec;12(1):3753-3771. doi: 10.1080/21655979.2021.1939514.
Eur Radiol. 2020 Oct;30(10):5370-5373. doi: 10.1007/s00330-020-06937-z. Epub 2020 May 28.
4
Therapeutic Approach to Low-Grade Serous Ovarian Carcinoma: State of Art and Perspectives of Clinical Research.低度浆液性卵巢癌的治疗方法:临床研究现状与展望
Cancers (Basel). 2020 May 23;12(5):1336. doi: 10.3390/cancers12051336.
5
Does dual-energy CT differentiate benign and malignant ovarian tumours?双能CT能否鉴别卵巢良恶性肿瘤?
Clin Radiol. 2020 Aug;75(8):606-614. doi: 10.1016/j.crad.2020.03.006. Epub 2020 Apr 4.
6
MR imaging findings of low-grade serous carcinoma of the ovary: comparison with serous borderline tumor.卵巢低级别浆液性癌的 MRI 表现:与浆液性交界性肿瘤的比较。
Jpn J Radiol. 2020 Aug;38(8):782-789. doi: 10.1007/s11604-020-00960-2. Epub 2020 Apr 3.
7
Low-grade Serous Tumors: Are We Making Progress?低级别浆液性肿瘤:我们是否取得进展?
Curr Oncol Rep. 2020 Jan 27;22(1):8. doi: 10.1007/s11912-020-0872-5.
8
Ovarian-Adnexal Reporting Data System Magnetic Resonance Imaging (O-RADS MRI) Score for Risk Stratification of Sonographically Indeterminate Adnexal Masses.卵巢-附件报告数据系统磁共振成像(O-RADS MRI)评分用于超声不确定附件肿块的风险分层。
JAMA Netw Open. 2020 Jan 3;3(1):e1919896. doi: 10.1001/jamanetworkopen.2019.19896.
9
Low-grade serous ovarian cancer: State of the science.低级别浆液性卵巢癌:科学现状。
Gynecol Oncol. 2020 Mar;156(3):715-725. doi: 10.1016/j.ygyno.2019.12.033. Epub 2020 Jan 20.
10
O-RADS US Risk Stratification and Management System: A Consensus Guideline from the ACR Ovarian-Adnexal Reporting and Data System Committee.O-RADS US 风险分层与管理系统:ACR 卵巢-附件报告和数据系统委员会的共识指南。
Radiology. 2020 Jan;294(1):168-185. doi: 10.1148/radiol.2019191150. Epub 2019 Nov 5.